← All Sponsors

SPONSOR

Aadi Bioscience, Inc.

Total Trials

1

Recruiting

1

Phases

Phase 1

Conditions studied: Tumor, Solid Tumor Advanced Solid Tumor

NCT05661461 Phase 1

Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment